I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
Jonathan Allen Webster, M.D.
Assistant Professor of Oncology
Specializes in: Adults (18+ years)
Expertise: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Internal Medicine, Oncology
Research Interests: Immunotherapy; Acute Leukemias
Request an Appointment
I live in Maryland
Request an appointment through My
I live outside of Maryland
I live outside of the United States
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Appointment Phone: 410-955-8893
401 N. Broadway
Baltimore, MD 21231 map
Dr. Webster attended medical school at Stanford University followed by residency and fellowship training at Johns Hopkins Hospital. He is a medical oncologist specializing in adult leukemia. He primarily sees patients with acute lymphoblastic leukemia, chronic myeloid leukemia, and acute myeloid leukemia. His research focuses on the treatment of acute lymphoblastic leukemia including the incorporation of novel therapies as well the treatment and prevention of central nervous system leukemia. He is also actively involved in developing trials incorporating immunotherapy into the treatment of leukemia and developing new strategies to prevent leukemia relapse following allogeneic hematopoietic stem cell transplant.
- Assistant Professor of Oncology
- MD, Stanford University School of Medicine (2011)
- Johns Hopkins University School of Medicine / Internal Medicine (2014)
- Johns Hopkins University School of Medicine / Medical Oncology (2017)
- American Board of Internal Medicine / Internal Medicine (2014)
- American Board of Internal Medicine / Medical Oncology (2016)
Research & Publications
Acute lymphoblastic leukemia
Acute myeloid leukemia
Chronic myeloid leukemia
Webster JA, Tibes R, Morris L, Blackford AL, Litzow M, Patnaik M, Rosner GL, Gojo I, Kinders R, Wang L, Doyle LA, Huntoon CJ, Karnitz LM, Kaufmann SH, Karp JE, Smith BD. Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia. Leuk Res. 2017;61:108-116
Webster JA, Pratz KW. Acute myeloid leukemia in the elderly: therapeutic options and choice. Leuk Lymphoma. 2018 Feb; 59(2): 274
Contact for Research Inquiries
1650 Orleans St., CRB1 Room 245
Baltimore, MD 21287 map
Activities & Honors
- American Society of Hematology, 2015
- American Society of Clinical Oncology, 2014